Evidence map›Paper›PMID 36275122›Full record

ArticleACS omega2022

microRNA 1307 Is a Potential Target for SARS-CoV-2 Infection: An

Elif Damla Arisan, D Alwyn Dart, Guy H Grant, Andrew Dalby, Derya Dilek Kancagi, Raife Dilek Turan, Bulut Yurtsever, Gozde Sir Karakus, Ercument Ovali, Sigrun Lange and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Elif Damla ArisanGebze Technical University, Institute of Biotechnology, Gebze, Kocaeli 41400, Turkiye.
D Alwyn DartInstitute of Medical and Biomedical Education, St George's University of London, Cranmer Terrace, Tooting, London SW17 0RE, United Kingdom.
Guy H GrantSchool of Life Sciences, University of Bedfordshire, Park Square, Luton LU1 3JU, United Kingdom.
Andrew DalbySchool of Life Sciences, University of Westminster, London W1W 6UW, United Kingdom.
Derya Dilek KancagiAcibadem Labcell Cellular Therapy Laboratory, İstanbul 34457, Turkiye.
Raife Dilek TuranAcibadem Labcell Cellular Therapy Laboratory, İstanbul 34457, Turkiye.
Bulut YurtseverAcibadem Labcell Cellular Therapy Laboratory, İstanbul 34457, Turkiye.
Gozde Sir KarakusAcibadem Labcell Cellular Therapy Laboratory, İstanbul 34457, Turkiye.
Ercument OvaliAcibadem Labcell Cellular Therapy Laboratory, İstanbul 34457, Turkiye.
Sigrun LangeTissue Architecture and Regeneration Research Group, School of Life Sciences, University of Westminster, London W1W 6UW, United Kingdom.
Pinar Uysal-OnganerCancer Research Group, School of Life Sciences, University of Westminster, London W1W 6UW, United Kingdom.ORCID https://orcid.org/0000-0003-3190-8831
Acıbadem Adana Hospital · TRUniversity of Westminster · GBGebze Technical University · TRSt George's, University of London · GBUniversity of Bedfordshire · GBYeditepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

microRNAs (miRs) are proposed as critical molecular targets in SARS-CoV-2 infection. Our recent

Identifiers

PMID36275122
PMCPMC9578367
OpenAlexW4304609427

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.